WHO ICTRP trial

Comparison of the effect of saline nebulizer 5% with Ventolin VS saline…

IRCT20230930059568N1 · Iranian Registry of Clinical Trials (IRCT) · Recruiting

Key facts

Trial ID IRCT20230930059568N1
Public title Comparison of the effect of saline nebulizer 5% with Ventolin VS saline nebulizer 0.9% in the management of moderate asthma attack
Scientific title Comparison of the effect of saline nebulizer 5% with Ventolin VS saline nebulizer 0.9% in the management of moderate asthma attack
Primary sponsor Mazandaran University of Medical Sciences
Registry Iranian Registry of Clinical Trials (IRCT)
Recruitment status Recruiting
Study type interventional
Phase 3
Countries Iran (Islamic Republic of)
Conditions Moderate Asthma. Moderate persistent asthma, uncomplicated;J45.40
Interventions Intervention 1: Intervention group: In the intervention group, a vial of salbutamol (Ventolin, salbutamol sulfate 0.15 mg per kg with a minimum dose of 2.5 mg) in 2.5 mL of 5% hypertonic saline (minimum volume of 5 cc) is prescribed for 20…
Registration date Dec 26, 2023
Target size 40
Registry page irct.behdasht.gov.ir

At a glance

  • No Results available

Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.

About WHO ICTRP trial registrations

The WHO ICTRP combines trial registrations from primary registries worldwide into a single searchable index. Contact and ethics-committee details are not shown here.

Source: World Health Organization (WHO), International Clinical Trials Registry Platform (ICTRP) · Source date:

Browse all WHO ICTRP trial registrations